Adria Cimino is a contributing Motley Fool stock market analyst covering healthcare, technology, and consumer goods sectors. Prior to The Motley Fool, Adria covered the European stock market and U.S.

Collectively, analysts tracking the stock expect declines in both revenue and profitability. The company continues to effect a major pivot in its business. Teva's transformation strategy, the ...

Three sectors that could be the most at risk for share-price disruption are cybersecurity, banking, and cryptocurrency stocks. And among these sectors, a handful of companies could potentially feel ...

Poet's dramatic valuation pullback today came despite a relatively calm backdrop for the broader market. The S&P 500's level ...

Amazon generates higher revenue and profits. Yet it also generally grows its top line faster than Costco. And on top of that, ...

If Novo Nordisk's initiatives work and the company can cut the cost and time to develop drugs by even 5%, that could have a ...

The telecom giant's latest results highlighted impressive growth and strong guidance, further securing its robust dividend.

Eli Lilly is best known for its work in the weight loss market. The company has billion-dollar drugs in other areas. The ...

These three healthcare giants have dealt with slow revenue growth in recent years. All three have continued to increase their ...

Some stocks saw massive surges during the early pandemic years because their businesses were well-positioned to perform well ...

Nokia rose after an analyst upgrade pointed to stronger demand in optical transport and IP routing, with data center ...

While artificial intelligence (AI) stocks have bounced back to lead the market higher, the same can't be said for growth ...